German startup Pieris hopes they could prove a cheaper alternative to antibodies. (Click here for company profile.) The structure of lipocalins was first elucidated during the early 1980s ...

Pieris Pharmaceuticals’ long-standing immuno-oncology alliance with Servier is being dissolved after a clinical trial of the lead drug in the alliance revealed a safety concern. In a Securities ...

BOSTON, MA / ACCESSWIRE / April 19, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A hedge fund recently bought a new stake in Pieris Pharmaceuticals stock. Frazier Life Sciences Management L.P. purchased a new stake in Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS – Free Report) in the ...

BOSTON (AP) — BOSTON (AP) — Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $2.9 million in its third quarter. On a per-share basis, the Boston-based company said it had a ...

Richard Pieris Group, one of Sri Lanka’s largest and most diversified conglomerates, recorded a Profit Before Tax (PBT) of Rs. 3.59 billion in the first six months of the 2024/25 financial year, ...

Saliya Pieris, PC, stated that there is no basis for claims made by certain factions that the Prime Minister and Cabinet ...